Marius SUDOL
Co-Principal Investigator, Mechanobiology Institute, National University of Singapore
mbims@nus.edu.sg | phsms@nus.edu.sg
+65 6601 1402
Level 10 T-Lab
National University of Singapore
5A Engineering Drive 1
Singapore 117411
Research Program
The Cell-Matrix and Cell-Cell Mechanotransduction Group
Affiliations
Associate Professor, Yong Loo Lin School of Medicine, Department of Physiology, NUS, Institute for Molecular and Cell Biology (IMCB, AStar)
Marius Sudol
Co-Principal Investigator
Research Areas
- Investigations into physiological and molecular mechanisms of the Golabi-Ito-Hall syndrome, which phenocopies severe autism, using transgenic animal models of the syndrome
- Investigations into the role of tight junctions proteins such as ZO2 and ZO1 in the regulation of the Hippo-YAP tumor suppressor pathway using cell and animal models
- Investigations of new signaling modalities that inhibit YAP oncogene and could be translated into cancer drug discovery
- Investigations of a cross talk between WW domain-containing proteins that regulate muscle homeostasis and the Hippo-YAP pathway that controls differentiation and stem cell biology
- Investigations into the dominant role of Hippo-YAP tumor suppressor pathway in liver regeneration
Research Interests
Among Prof Sudol’s most significant achievements to date are the identification of a modular protein domain, known as the WW domain, and the characterization of its cognate ligands. In 2004, together with a research team at AxCell-Cytogen company, Marius Sudol reported the first comprehensive protein interaction map for a human modular domain. Today, the WW domain is known to mediate critical signals in tumor suppressor networks, including the Hippo signaling pathway. More importantly, syndromes such as the Golabi-Ito-Hall syndrome of intellectual disability and Liddle syndrome of hypertension are caused by loss-of-function point mutations in the WW domain or its cognate ligands.
Biography
The research conducted in Marius Sudol’s laboratory and those of his collaborators over the past two decades has directly contributed to a systems biology level understanding of signaling networks from the perspective of modular protein domains. As a co-founder and co-leader of the Protein Modules Consortium, he advocates systems biology approaches and synthetic biology strategies in designing therapeutic interventions based on the knowledge of the structure and function of protein modules.
Over the course of his scientific career spanning more than three decades, Marius Sudol has authored 130 publications, including original research articles and invited reviews in refereed journals as well as numerous book chapters. His current work focuses on the role of WW domain-containing proteins in the Hippo tumor suppressor network and Golabi-Ito-Hall syndrome of intellectual disability.
Education
PhD The Rockefeller University, New York City, USA
Recent Publications
- Lee CJM, Autio MI, Zheng WH, Song Y, Wang SC, Wong DCP, Xiao J, Zhu Y, Yusoff P, Yei X, Chock WK, Low BC, Sudol M, and Foo RS. Genome-Wide CRISPR Screen Identifies an NF2-Adherens Junction Mechanistic Dependency for Cardiac Lineage. Circulation 2024;. [PMID: 38752370]
- Toh PJY, Sudol M, and Saunders TE. Optogenetic control of YAP can enhance the rate of wound healing. Cell Mol Biol Lett 2023; 28(1):39. [PMID: 37170209]
- Toh PJY, Lai JKH, Hermann A, Destaing O, Sheetz MP, Sudol M, and Saunders TE. Optogenetic control of YAP cellular localisation and function. EMBO Rep 2022;:e54401. [PMID: 35876586]
- Zhu B, Finch-Edmondson M, Leong KW, Zhang X, V M, Lin QXX, Lee Y, Ng WT, Guo H, Wan Y, Sudol M, and DasGupta R. LncRNA SFTA1P mediates positive feedback regulation of the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer. Cell Death Discov 2021; 7(1):369. [PMID: 34845189]
- Vrbský J, Vinarský V, Perestrelo AR, Oliver-De La Cruz J, Martino F, Pompeiano A, Izzi V, Hlinomaz O, Rotrekl V, Sudol M, Pagliari S, and Forte G. Corrigendum to "Evidence for discrete modes of YAP1 signaling via mRNA splice isoforms in development and disease" [Genomics 113 (2021) 1349-1365]. Genomics 2021;. [PMID: 34544621]
- Vrbský J, Vinarský V, Perestrelo AR, De La Cruz JO, Martino F, Pompeiano A, Izzi V, Hlinomaz O, Rotrekl V, Sudol M, Pagliari S, and Forte G. Evidence for discrete modes of YAP1 signaling via mRNA splice isoforms in development and diseases. Genomics 2021;. [PMID: 33713822]
- Zhu B, V M, Finch-Edmondson M, Lee Y, Wan Y, Sudol M, and DasGupta R. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer. Cancers (Basel) 2021; 13(4). [PMID: 33670427]
- Lee Y, Finch-Edmondson M, Cognart H, Zhu B, Song H, Chuan LB, and Sudol M. Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells. Cancers (Basel) 2020; 12(12). [PMID: 33297432]
- Tabatabaeian H, Rao A, Ramos A, Chu T, Sudol M, and Lim YP. The emerging roles of WBP2 oncogene in human cancers. Oncogene 2020;. [PMID: 32393834]
- Shepley-McTaggart A, Fan H, Sudol M, and Harty RN. Viruses go modular. J. Biol. Chem. 2020; 295(14):4604-4616. [PMID: 32111739]